Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Journal of Immunology (Baltimore, Md. : 1950)|July 29, 2026
CD8+ T-cell effector programming is epigenetically regulated by DUSP2 through BAF complex-driven chromatin remodelingEmilia R Dellacecca, Jacob B Hirdler, Whitney Barham, et al.Immunohorizons|January 19, 2023
A Novel Humanized PD-1/PD-L1 Mouse Model Permits Direct Comparison of Antitumor Immunity Generated by Food and Drug Administration-Approved PD-1 and PD-L1 InhibitorsWhitney Barham, Michelle Hsu, Xin Liu, et al.Cancer Immunology Research|August 18, 2025
A Dual Role for NKG7 in T-cell Cytotoxicity and LongevityHaidong Dong, Hyoungjun Ham, Whitney Barham, et al.Journal for Immunotherapy of Cancer|October 28, 2025
Targeting PD-L1-CMTM6 interactions in myeloid cells triggers PD-L1 degradation and enhances cytotoxic T-cell expansionMichelle A Hsu, Xin Liu, Whitney Barham, et al.Biorxiv : the Preprint Server for Biology|January 27, 2025
PD-1 prelimits both the cytotoxic and exhaustion potential in thymic CD8+ T cells and impacts the maintenance of peripheral tumor immunityZhiming Mao, Jacob B Hirdler, Joanina K Gicobi, et al.JCI Insight|March 5, 2026
TNF-α Blockade Mitigates Immune Checkpoint-Related Nephritis in a Humanized Mouse ModelVictor D Cuenca Narvaez, Coraima Nava Chavez, Omar Al Refai, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 10, 2023
A Novel PD-L1 Antibody Promotes Antitumor Function of Peripheral Cytotoxic Lymphocytes after Radical Nephrectomy in Patients with Renal Cell CarcinomaZesheng An, Michelle A Hsu, Joanina K Gicobi, et al.Nature Communications|May 23, 2026
PD-1 regulates latent effector differentiation of thymic cytotoxic CD8+ T cellsZhiming Mao, Jacob B Hirdler, Joanina K Gicobi, et al.Science Advances|November 15, 2023
Salvage therapy expands highly cytotoxic and metabolically fit resilient CD8+ T cells via ME1 up-regulationJoanina K Gicobi, Zhiming Mao, Grace DeFranco, et al.Advanced Biology|March 28, 2022
Understanding Suboptimal Response to Immune Checkpoint InhibitorsMojun Zhu, Henan Zhang, Katrina S Pedersen, et al.Pageof 2